Navigation Links
Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
Date:9/22/2010

PITTSBURGH, Sept. 22 /PRNewswire/ -- Precision Therapeutics announced today that President and Chief Executive Officer Sean McDonald received the Smart Business Magazine 2010 Pacesetters Award.  The award honors thirteen regional Pacesetters and recognizes the impact of their influence in the community-at-large as well as within their own organizations. The event took place on Tuesday, September 21st at the Kean Theatre in The Washington Place, Gibsonia, Pennsylvania.  Mr. McDonald was recognized as a leader in the mid-sized company category who is setting the pace for the Pittsburgh region.

(Photo: http://photos.prnewswire.com/prnh/20100922/NE69963 )

(Photo: http://www.newscom.com/cgi-bin/prnh/20100922/NE69963 )

"Being named a Smart Business Pacesetter is such an honor for me and my team as we work toward our goal of optimizing each patient's quality of life and chance for survival by designing advanced technology that offers hope for personalized cancer treatment," said McDonald.  "It is great to see that Pittsburgh is receiving recognition as a leader in the growing life science industry and a privilege to be a part of that development."

McDonald joined Precision Therapeutics in 2001 and serves as President and CEO. Previously, Mr. McDonald founded Automated Healthcare in 1992, developing the first robotics-based solution to hospital pharmacy management.  Mr. McDonald grew the company to over $150 million in revenues when it was acquired by the McKesson Corporation in 1996.

About Precision Therapeutics

Precision Therapeutics, a life-science company based in Pittsburgh, Pennsylvania, is committed to improving outcomes of cancer patients.  As leaders in the science of individualizing cancer therapy through the use of a proprietary and unique live-tissue platform, Precision develops novel markers to help guide treatment decisions based on the biological processes of each individual's cancer.

Precision's state of the art bioinformatics combined with the analysis of the live molecular, proteomic and genomic activity of each patient's cancer offer an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy.  Precision's first commercial test, ChemoFx®, is a proprietary drug response marker which measures an individual's malignant tumor response to a range of standard therapeutic alternatives under consideration by a physician.  For more information, please visit www.precisiontherapeutics.com

About Pacesetters

The Pacesetter Awards are designed to recognize business leaders in the Greater Pittsburgh Area who are setting the pace for the region.  Leaders are recognized in three divisions based on the size of their organization, its revenue and overall story of success and influence within the organization as well as the community at large.

For more information, please visit www.sbnonline.com.


'/>"/>
SOURCE Precision Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Experts Detail How They Use Varians TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments
2. Applied Precisions Mobile Imaging Lab Hits the Road for a Cross-Country Journey
3. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
4. Precision Bearing Technologies Featured at Atlantic Design & Manufacturing Show
5. Applied Precision Announces New Products for Life Sciences Microscopy at the 110th American Society for Microbiology Meeting in San Diego, CA, May 23-26th.
6. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
7. Echo Therapeutics Initiates Needle-Free Biosensor Program for Continuous Lactate Monitoring
8. Signum Biosciences Awarded Two Additional NIH Grants for Development of Topical Therapeutics
9. CoDa Therapeutics NEXAGON® Wound Healing Gel Named to Windhovers Top 10 HOT SPACE Projects to Watch
10. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
11. Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
(Date:4/18/2017)... Viverae ® , a leader in workplace ... IBM ® Watson Campaign Automation, implementing behavioral messaging ... a personalized experience. Through digital engagement, the platform prompts ... real time. The enhanced experience drives engagement by focusing ... they are in their journey to health. ...
Breaking Medicine Technology:
(Date:4/29/2017)... ... April 29, 2017 , ... ... and recognize the positive impact veterinarians have on animal health and welfare as ... Organization for Animal Health (OIE) choose a theme each year and this year ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... National Campaign) announces its support for the Access to Contraception for Women Servicemembers ... (D-NH) and Rep. Jackie Speier (D-CA), will help to ensure that all members ...
(Date:4/28/2017)... ... April 28, 2017 , ... It's not always common knowledge whether or not ... are unclear as to whether or not they are contagious, and most people don't ... illnesses. So, FindaTopDoc took a look into the matter. , They discovered that ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... , ... Getting enough sleep affects much more than energy – it also has mental and ... can compromise motor reaction time, which can increase the risk of having a car accident. ... tips from the NSF to help you sleep better and feel better:, ...
Breaking Medicine News(10 mins):